Neutralizing Antibodies Limit Cell-Associated Spread of Human Cytomegalovirus in Epithelial Cells and Fibroblasts

Human cytomegalovirus (HCMV) can cause severe clinical disease in immunocompromised individuals, such as allograft recipients and infants infected in utero. Neutralizing activity of antibodies, measured as the ability to prevent the entry of cell-free virus, has been correlated with the reduction in...

Descripción completa

Detalles Bibliográficos
Autores principales: Reuter, Nina, Kropff, Barbara, Britt, William J., Mach, Michael, Thomas, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875165/
https://www.ncbi.nlm.nih.gov/pubmed/35215877
http://dx.doi.org/10.3390/v14020284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875165/
https://www.ncbi.nlm.nih.gov/pubmed/35215877
http://dx.doi.org/10.3390/v14020284

Ejemplares similares